Literature DB >> 10975688

Psychostimulants in supportive care.

J Homsi1, D Walsh, K A Nelson.   

Abstract

Psychostimulant medications have been used clinically and investigated in psychiatric populations, the medically ill, cancer patients and healthy people. This article discusses the pharmacology of dextroamphetamine, methylphenidate, pemoline (and other psychostimulants such as caffeine and ephedrine), their use in general medicine and cancer care, side effects, and abuse potential. Therapeutic use in children is addressed only insofar as it illustrates facets of their use in adults.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10975688     DOI: 10.1007/s005200050007

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  7 in total

1.  Cancer fatigue--more data, less information?

Authors:  Susan B LeGrand
Journal:  Curr Oncol Rep       Date:  2002-07       Impact factor: 5.075

2.  Cancer-related depression and potential pharmacologic therapies.

Authors:  Aimee Ginsburg
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-10

Review 3.  Underutilisation of opioids in elderly patients with chronic pain: approaches to correcting the problem.

Authors:  Kirsten Auret; Stephan A Schug
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 4.  Psychopharmacology in psycho-oncology.

Authors:  Rosangela Caruso; Luigi Grassi; Maria Giulia Nanni; Michelle Riba
Journal:  Curr Psychiatry Rep       Date:  2013-09       Impact factor: 5.285

Review 5.  Management of fatigue in cancer patients.

Authors:  Mellar P Davis; Dilara Khoshknabi; Guang H Yue
Journal:  Curr Pain Headache Rep       Date:  2006-08

6.  Methylphenidate side effects in advanced cancer: a retrospective analysis.

Authors:  Wael Lasheen; Declan Walsh; Fade Mahmoud; Mellar P Davis; Nilo Rivera; Dilara Seyidova Khoshknabi
Journal:  Am J Hosp Palliat Care       Date:  2009-09-10       Impact factor: 2.500

7.  A phase III double-blind placebo-controlled randomized study of dexamphetamine sulfate for fatigue in primary brain tumors patients: An ANOCEF trial (DXA).

Authors:  Florence Laigle-Donadey; François Ducray; Matthieu Boone; Mamadou Hassimiou Diallo; David Hajage; Carole Ramirez; Olivier Chinot; Damien Ricard; Jean-Yves Delattre
Journal:  Neurooncol Adv       Date:  2019-11-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.